Global Search | Novartis

Sort by

Relevance

Newest first

Oldest first

Hide Filters

Showing 2764 results

Press release / Jan 09, 2026

Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment

New 35,000-square-foot facility in Winter Park will expand RLT manufacturing footprint to optimize delivery for patients across southeastern USPurpose-built facility will strengthen Novartis RLT…
Press release / Oct 29, 2025

Novartis ianalumab first drug to reduce disease activity and patient burden in Sjögren’s disease Phase III trials

NEPTUNUS-1 and NEPTUNUS-2 achieved primary objective of reduced disease activity and provided clinically meaningful benefit1 Data showed consistent improvements across secondary…
Clinical Trials / Apr 02, 2026

Real-World Treatment Pattern and Clinical Outcome With Influential Factors of HR+/HER2-aBC 1L Patients in China
Clinical Trials / Apr 02, 2026

Impact of Implementation Strategies on Lp(a) Testing in Secondary Care Settings
Clinical Trials / Apr 01, 2026

Real-world Study of Scemblix in the Treatment of Chronic Myeloid Leukemia in China
Clinical Trials / Apr 01, 2026

A Study to Assess the Effects of Zigakibart on IgA Nephropathy.
Clinical Trials / Mar 20, 2026

Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia
Clinical Trials / Mar 30, 2026

A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo
Clinical Trials / Mar 30, 2026

A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
Clinical Trials / Mar 30, 2026

A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration